HPA axis dysfunction: Is it a trait marker for bipolar disorder?

2015 ◽  
Vol 61 ◽  
pp. 52
Author(s):  
Fabrice Duval ◽  
Marie-Claude Mokrani ◽  
Alexis Erb ◽  
Felix Gonzalez Lopera ◽  
Xenia Proudnikova ◽  
...  
2006 ◽  
Vol 18 (5) ◽  
pp. 193-209 ◽  
Author(s):  
Richard J. Porter ◽  
Peter Gallagher

Background:New evidence is emerging regarding abnormalities of hypothalamic-pituitary-adrenal (HPA) axis function in subtypes of affective disorders. Adverse effects of HPA axis dysregulation may include dysfunction of monoaminergic transmitter systems, cognitive impairment and peripheral effects. Newer treatments specifically targeting the HPA axis are being developed.Objective:To review these developments focusing particularly on the glucocorticoid receptor (GR) antagonist mifepristone.Method:A selective review of the literature.Results:The function of GRs is increasingly being defined. The role of corticotrophin-releasing hormone (CRH) and dehydroepiandrosterone (DHEA) in the brain is also increasingly understood. HPA axis function is particularly likely to be abnormal in psychotic depression and bipolar disorder, and it is in these conditions that trials of the GR antagonist mifepristone are being focused. CRH antagonists and DHEA are also being investigated as potential treatments.Conclusion:Initial studies of mifepristone and other HPA-axis-targeting agents in psychotic depression and bipolar disorder are encouraging and confirmatory studies are awaited.


2016 ◽  
Vol 63 ◽  
pp. 327-342 ◽  
Author(s):  
Martino Belvederi Murri ◽  
Davide Prestia ◽  
Valeria Mondelli ◽  
Carmine Pariante ◽  
Sara Patti ◽  
...  

Author(s):  
Antonin Šebela ◽  
Tomas Novak ◽  
Michal Goetz

2015 ◽  
Vol 25 (3) ◽  
pp. 106-111 ◽  
Author(s):  
Marie E. Breen ◽  
Fayaz Seifuddin ◽  
Peter P. Zandi ◽  
James B. Potash ◽  
Virginia L. Willour

2008 ◽  
Vol 275 (1645) ◽  
pp. 1839-1848 ◽  
Author(s):  
Kristine Krug ◽  
Emma Brunskill ◽  
Antonina Scarna ◽  
Guy M Goodwin ◽  
Andrew J Parker

Slowing of the rate at which a rivalrous percept switches from one configuration to another has been suggested as a potential trait marker for bipolar disorder. We measured perceptual alternations for a bistable, rotating, structure-from-motion cylinder in bipolar and control participants. In a control task, binocular depth rendered the direction of cylinder rotation unambiguous to monitor participants' performance and attention during the experimental task. A particular direction of rotation was perceptually stable, on average, for 33.5 s in participants without psychiatric diagnosis. Euthymic, bipolar participants showed a slightly slower rate of switching between the two percepts (percept duration 42.3 s). Under a parametric analysis of the best-fitting model for individual participants, this difference was statistically significant. However, the variability within groups was high, so this difference in average switch rates was not big enough to serve as a trait marker for bipolar disorder. We also found that low-level visual capacities, such as stereo threshold, influence perceptual switch rates. We suggest that there is no single brain location responsible for perceptual switching in all different ambiguous figures and that perceptual switching is generated by the actions of local cortical circuitry.


2016 ◽  
Vol 26 ◽  
pp. S425
Author(s):  
S.L. Romero Guillena ◽  
O. Santamaria ◽  
B.O. Plasencia Garcia de Diego ◽  
R. Navarro ◽  
F. Gotor Sanchez-Luengo

2004 ◽  
Vol 184 (6) ◽  
pp. 496-502 ◽  
Author(s):  
Stuart Watson ◽  
Peter Gallagher ◽  
James C. Ritchie ◽  
I. Nicol Ferrier ◽  
Allan H. Young

BackgroundHypothalamic-pituitary-adrenal (HPA) axis function, as variously measured by the responses to the combined dexamethasone/ corticotrophin-releasing hormone (dex/ CRH) test, the dexamethasone suppression test (DST) and basal cortisol levels, has been reported to be abnormal in bipolar disorder.AimsTo test the hypothesis that HPA axis dysfunction persists in patients in remission from bipolar disorder.MethodSalivary cortisol levels and the plasma cortisol response to the DST and dex/CRH test were examined in 53 patients with bipolar disorder, 27 of whom fulfilled stringent criteria for remission, and in 28 healthy controls. Serum dexamethasone levels were measured.ResultsPatients with bipolar disorder demonstrated an enhanced cortisol response to the dex/CRH test compared with controls (P=0.001). This response did not differ significantly between remitted and non-remitted patients. These findings were present after the potentially confounding effects of dexamethasone levels were accounted for.ConclusionsThe dex/CRH test is abnormal in both remitted and non-remitted patients with bipolar disorder. Thismeasure of HP Aaxis dysfunction is a potential trait marker in bipolar disorder and thus possibly indicative of the core pathophysiological process in this illness.


2015 ◽  
Vol 31 (1) ◽  
pp. 183-189 ◽  
Author(s):  
Shareefa Dalvie ◽  
Chiara Fabbri ◽  
Raj Ramesar ◽  
Alessandro Serretti ◽  
Dan J. Stein

Sign in / Sign up

Export Citation Format

Share Document